Skip to content

A multicenter, randomized, double-blind, controlled clinical study of esketamine in the prevention of postpartum depression in women undergoing cesarean section

A multicenter, randomized, double-blind, controlled clinical study of esketamine in the prevention of postpartum depression in women undergoing cesarean section

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085495
Enrollment
Unknown
Registered
2024-06-10
Start date
2024-06-10
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpartum depression

Interventions

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Those who intend to perform caesarean section under spinal anesthesia; 2) clearly understand and voluntarily participate in the study, and sign the informed consent form themselves.

Exclusion criteria

Exclusion criteria: 1) People with communication disorders; 2) People with high blood pressure during pregnancy or with severe cardiovascular diseases; 3) People with a history of hyperthyroidism; 4) People with a history of drug use; 5) People who are allergic to esketamine or with elevated intracranial pressure, elevated intraocular pressure and elevated intragastric pressure

Design outcomes

Primary

MeasureTime frame
Incidence of postpartum depression six weeks after operation;

Secondary

MeasureTime frame
Edinburgh Postpartum Depression scale score at 1 week, 2 weeks, 4 weeks and 6 weeks after operation;1, 2, 3 days of postoperative exercise and resting pain VAS score;Ramsay score of 5 minutes after drug injection, at the end of the operation, and 1 day after surgery;BPRS+ score of 5 minutes after drug injection, at the end of the operation, and 1 day after surgery;Postoperative Social Support Evaluation Scale Score at 6 Weeks;The times of PCA pressing, the total amount of drugs used and the use of remedial drugs;Vital signs (including heart rate, pulse oxygen and blood pressure) at 1min, 5min and 10min after drug injection and at the end of operation;

Countries

China

Contacts

Public ContactWei Ke

The First Affiliated Hospital of Chongqing Medical University

Wk202448@hospital-cqmu.com+86 159 0236 0621

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026